Autoradiographical Studies of in Vitro and Chronic in Vivo Effects of Propentofylline on Adenosine A1and A2Receptors and NBMPR-Sensitive Nucleoside Transporters

Abstract

Abstract Propentofylline is a novel xanthine that has been shown to limit the extent neuronal damage induced by cerebral ischemia in gerbils (DeLeo et al., 1987). This is in contrast to other xanthines, including, caffeine and theophylline, that increase the extent of damage (Rudolphi et al., 1987; Dux et al., 1987). Propentofylline has been demonstrated to decrease adenosine uptake into human erythrocytes (Fredholm and Lindstrom, 1986), and to increase extracellular concentration of adenosine in ischemic barain (Andine et al., 1990). Therefore, it was proposed that this compound provides protection in cerebral ischemia, in part, by adenosine receptor stimulation due to increased endogenous adenosine levels.